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Bichat-Beaujon CRB3, Clichy, France; 3Université Denis Diderot-Paris 7, 75018 Paris, FranceAutophagy, or cellular self-digestion, is a cellular pathway cru- reach lysosomes for degradation. Three types of autophagy (mac-
cial for development, differentiation, survival, and homeostasis.
Its implication in human diseases has been highlighted during
the last decade. Recent data show that autophagy is involved in
major ﬁelds of hepatology. In liver ischemia reperfusion injury,
autophagy mainly has a prosurvival activity allowing the cell
for coping with nutrient starvation and anoxia. During hepatitis
B or C infection, autophagy is also increased but subverted by
viruses for their own beneﬁt. In hepatocellular carcinoma, the
autophagy level is decreased. In this context, autophagy has an
anti-tumor role and therapeutic strategies increasing autophagy,
as rapamycin, have a beneﬁcial effect in patients. Moreover, in
hepatocellular carcinoma, Beclin-1 level, an autophagy protein,
has a prognostic signiﬁcance. In a-1-antitrypsin deﬁciency, the
aggregation-prone ATZ protein accumulates in the endoplasmic
reticulum. This activates the autophagic response which aims at
degrading mutant ATZ. Some FDA-approved drugs which
enhance autophagy and the disposal of aggregation-prone pro-
teins may be useful in a-1-antitrypsin deﬁciency. Following alco-
hol consumption, autophagy is decreased in liver cells, likely due
to a decrease in intracellular 50-AMP-activated protein kinase
(AMPk) and due to an alteration in vesicle transport in hepato-
cytes. This decrease in autophagy contributes to the formation
of Mallory-Denk bodies and to liver cell death. Hepatic autophagy
is defective in the liver in obesity and its upregulation improves
insulin sensitivity.
 2010 European Association for the Study of the Liver. Published
by Elsevier B.V. All rights reserved.
Deﬁnition and molecular machinery of autophagy
Autophagy (Greek for ‘‘self eating”) is a general term for pro-
cesses by which cytoplasmic materials, including organelles,Journal of Hepatology 20
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agy) have been identiﬁed and they differ with respect to their
physiological functions and mode of cargo delivery to the
lysosome.
This review will focus on macroautophagy (hereafter referred
to as autophagy), the major regulated catabolic mechanism that
eukaryotic cells use to degrade long-lived proteins and organelles
[1]. This pathway is conserved from yeast to mammals (Fig. 1).
Upon induction, a small vesicular sac called the isolation mem-
brane or phagophore elongates and subsequently encloses a por-
tion of cytoplasm, which results in the formation of a double-
membraned structure, the autophagosome (Fig. 2). Recent data
show that the outer membrane of mitochondria participates in
autophagosome biogenesis [2]. Then, the outer membrane of
the autophagosome fuses with a lysosome (to form an autolyso-
some), leading to the degradation of the enclosed materials
together with the inner autophagosomal membrane. Amino acids
and other small molecules that are generated by autophagic deg-
radation are delivered back to the cytoplasm for recycling or
energy production. Autophagy occurs at low basal levels in virtu-
ally all cells to perform homeostatic functions such as protein and
organelle turnover. It is rapidly upregulated through the inhibi-
tion of mammalian target of rapamycin (mTOR) when cells need
to generate intracellular nutrients and energy, for example, dur-
ing starvation, growth factor withdrawal, or high bioenergetic
demands [1,3]. Subsequently, prolonged starvation reactivates
mTOR signaling that both attenuates autophagy and generates
proto-lysosomal tubules and vesicles that extrude from autolyso-
somes and ultimately mature into functional lysosomes, thereby
restoring the full complement of lysosomes in the cell [4].
The execution of autophagy involves a set of evolutionarily
conserved gene products (initially identiﬁed in yeast) known as
the Atg proteins that are required for the formation of the isola-
tion membrane and the autophagosome. The process of auto-
phagosome formation involves three major steps described in
Fig. 3: initiation with the uncoordinated 51-like kinase 1
(ULK1) complex, nucleation with the Beclin-1-class III phosphati-
dylinositol 3-kinase (PI3K) complex and elongation of the isola-
tion membrane with a key role of microtubule-associated
protein light chain 3 (LC3) lipidation [3,5,6].
Information on the methods for monitoring autophagy can be
found elsewhere [7].
Within the past decade, numerous new techniques have been
developed, allowing to understand the role of autophagy both in10 vol. 53 j 1123–1134
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normal and in pathological conditions [1,5]. The physiological
role of autophagy in nutrient and energy metabolism in hepato-
cytes has been reviewed elsewhere [8]. As detailed in Box 1, this
process is particularly crucial in newborn mammals survival
[9,10]. Several recent studies have demonstrated the implication
of autophagy in major ﬁelds of hepatology. This review aims at
providing an overview of currently available knowledge on
autophagy and liver diseases.Autophagy and liver ischemia reperfusion and liver surgery
Liver ischemia/reperfusion injury occurs during liver transplanta-
tion, trauma, shock, and elective liver resection. During this pro-
cess, hypoxic organ damage is accentuated following the return
of blood ﬂow and oxygen delivery. The pathophysiology includes
direct cellular damage as a result of the ischemic insult and
delayed dysfunction and injury resulting from inﬂammatory
pathway activation [11].
As the ﬁrst known role of autophagy is its action during nutri-
ent starvation, studies on autophagy and liver diseases have rap-
idly focussed on liver ischemia/reperfusion [12–14]. Two types of
experimental protocols have been performed reﬂecting two dif-
ferent clinical situations: (a) hepatic ischemia induced by occlu-
sion of the portal triad for a duration ranging from 30 to
90 min, followed or not by a reperfusion period ranging from
30 min to 3 h [15–17]; and (b) liver transplantation with 24 h
cold ischemia followed by reperfusion [18–20].
Despite very similar protocols, results of studies performed in
mice, assessing the impact on autophagy of portal triad occlusion,
are highly controversial, some reporting an increase and others a
decrease in autophagy protein level [15–17]. Nevertheless, the
unique study performed in patients provides interesting informa-1124 Journal of Hepatology 2010tion [21]. In this study, 61 patients who underwent liver surgery
with total vascular occlusion and preservation of the caval ﬂow
after receiving several courses of chemotherapy were studied.
For all patients, two liver biopsies were taken, one before the pro-
longed ischemia required by liver resection and another after the
liver reperfusion (median: 88 min; range:57–125 min), before clo-
sure of the abdomen. A unique vascular occlusion had almost no
effect on autophagy, since the LC3-II rarely increased and the num-
ber of cells containing autophagic vacuoles remained stable. How-
ever, a subgroup of patients underwent ischemic preconditioning
consisting of 10 min of portal triad clamping followed by 10 min
of reperfusion before the prolonged ischemia required by liver
resection. In these patients, a frank increase in liver cell autophagy
was observed. Even if this study failed to demonstrate a beneﬁcial
effect of such ischemic preconditioning in postresection liver
injury tests or measure of patient morbidity [21], previous studies
including speciﬁc groups of patients, such as young patients and
patients with liver steatosis or cirrhosis obtained a clinical
improvement [22,23]. This suggests that in this context, autophagy
enhancement could allow for decreasing liver cell death (Table 1).
Studies on liver transplantation had also apparently contra-
dictory results. The explanation for such discrepancies must be
the solution for cold preservation used. Indeed, a decrease in
autophagy was observed in a study using a histidine–trypto-
phan–ketoglutarate cold-storage solution for 24 h cold preserva-
tion [20], while the contrary was reported by authors using the
University of Wisconsin (UW) cold-storage solution [18,19]. Elec-
tron microscopy analysis of surgical biopsies performed after
revascularisation of human liver grafts conserved in UW solution
also disclosed the existence of numerous autophagic vacuoles
(personal unpublished data). Importantly, UW cold storage solu-
tion does not contain amino acids. It is well demonstrated that
amino acid depletion rapidly induces autophagy [12] and that
anoxia decreases autophagy protein level [16]. This induction of
autophagy due to the absence of amino acids, may explain not
only the apparent discrepancy between these studies but also
the protection of the liver obtained with preservation solution
such as the UW solution [11]. Indeed, anoxia/reoxygenation
induces mitochondrial dysfunction. Due to the decrease in
autophagy proteins induced by anoxia/reoxygenation, autophagy
fails to remove dysfunctional mitochondria, so that the mito-
chondria laden with reactive oxygen species and calcium
undergo the mitochondrial permeability transition, which in turn
leads to uncoupling of oxidative phosphorylation, energetic fail-
ure, ATP depletion, and ultimately cell death. In case of associated
nutrient depletion, autophagy is enhanced and facilitates autoph-
agy of damaged mitochondria, leading to cell survival [16].
This hypothesis is supported by the beneﬁcial effect on liver
tolerance to ischemia–reperfusion of several strategies aiming
at increasing autophagy in murine models: stimulation of PPARc
with rosiglitazone, infusion of nontoxic doses of cisplatin and
liver graft hypothermic reconditioning by insufﬂation of gaseous
oxygen via the caval vein during the last 90 min of preservation,
[15,17,20]. It is striking to notice that the two studies suggesting
that inhibiting autophagy could ameliorate liver tolerance to
ischemia [14,18] used non speciﬁc inhibitors of autophagy, such
as general lysosome protease inhibitors (pepstatin and leupeptin)
or PI3K inhibitors (wortmannin or LY294002), known to also
have autophagy independent activities.
Currently available studies provide additional information.
First, autophagic activity declines in aged organisms whichvol. 53 j 1123–1134
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Fig. 1. Cellular and molecular aspects of autophagy. Note that wortmannin inhibits both class I (inhibitory) and class III PI3K, but the overall phenotypic effect is to
inhibit autophagy as represented here. Abbreviations: AMPk, adenosine monophosphate-activated protein kinase; Atg, autophagy genes; Bcl-2, B-cell leukemia/lymphoma
2; mTOR, mammalian target of rapamycin; PI3K, phosphatidylinositol 3-kinase.
JOURNAL OF HEPATOLOGYcould explain at least partly theworse tolerance to ischemia reper-
fusion in aged patients [15,24]. Second, autophagy level decreases
following partial hepatectomy suggesting a shift from the physio-
logical steady state between anabolismand catabolism to the posi-
tive balance which is required for the compensatory growth of the2 µm 
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Fig. 2. Electron micrographs showing ultrastructure of hepatocytes from a chro
magniﬁcation image showing hepatocytes containing several autophagic vacuoles (origin
vacuole (original magniﬁcation, 100,000). F, ﬁbrosis; ld, lipid droplet; m, mitochondria
Journal of Hepatology 2010liver after partial hepatectomy [13]. Third, reperfusion had more
effect on autophagy level than ischemia alone [16,19,25], which
is in linewith the histological lesions observed [11]. Unfortunately,
no study has yet speciﬁcally evaluated the autophagic pathway in
liver sinusoidal endothelial cells. This is a limitation inunderstand-m 
0.2 m 
nic hepatitis C patient. Black arrows point to autophagic vacuoles. (A) Low-
al magniﬁcation, 8000). (B) Partial view of a hepatocyte containing an autophagic
; n, nucleus.
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Fig. 3. Basic molecular machinery of autophagy. There are at least three steps
in the formation of autophagosomes: initiation, nucleation, and elongation/
closure. Autophagy is initiated by the ULK1 complex. This complex is formed by
ULK1 Ser/Thr protein kinase, Atg13, and FIP200. Among the initial steps of vesicle
nucleation is the activation of the class III PI3K (Vps34) to generate phosphati-
dylinositol 3-phosphate. This activation depends on the formation of a multi-
protein complex that includes Beclin-1, Vps15, Atg14L (Atg14-like protein), and
Ambra1. Beclin-1 constitutively interacts with Bcl-2 or its close homolog Bcl-XL
and autophagy induction requires the dissociation of Beclin-1 from its inhibitors
Bcl-2 or Bcl-XL [6]. The functional relationship between the ULK1 complex
(initiation) and Beclin-1-class III PI3K complex (nucleation) complexes remains to
be determined [86]. Vesicle elongation, vesicle completion. The membrane
formed elongates and closes on itself to form an autophagosome. Two conjuga-
tion systems are successively involved. The ﬁrst involves the covalent conjugation
of Atg12 to Atg5, with the help of Atg7 and Atg10. This conjugate is organized into
a complex by associating with Atg16 to form the Atg16–Atg5–Atg12 complex. The
second involves the conjugation of phosphatidylethanolamine (PE) to a LC3 by
the sequential action of the Atg4, Atg7, and Atg3. This lipid conjugation leads to
the conversion of the soluble form of LC3 (named LC3-I) to the autophagic vesicle-
associated form (LC3-II), allowing for the closure of the autophagic vacuole.
Abbreviations: Ambra1, activating molecule in Beclin-1-regulated autophagy; Atg,
autophagy genes; Bcl, B-cell leukemia/lymphoma; FIP200, 200-kDa focal adhe-
sion kinase family-interacting protein; LC3, microtubule-associated protein light
chain 3; mTOR, mammalian target of rapamycin; PI3K, phosphatidylinositol
3-kinase; ULK1, uncoordinated 51-like kinase 1; Vps, vacuolar protein sorting.
Reviewing the effect of autophagy in liver ischemia reperfusion injury
since these cells are the most sensitive to ischemia and lesions to
these cells are a key event in this context.Autophagy and viral hepatitis
Besides the physiological function of autophagy in maintaining
cellular homeostasis, autophagy is a newly recognized facet of
innate and adaptative immunity. Not surprisingly, certain viruses
such as hepatitis C virus (HCV) and hepatitis B virus (HBV) have
developed strategies to subvert or use autophagy for their own
beneﬁt [26] (Table 1).
Several studies have assessed the autophagic pathway in
hepatocytes infected with HCV both in vitro and in liver biopsies1126 Journal of Hepatology 2010from chronic hepatitis C patients [27–32]. Whatever the
approach used (LC3, Atg5 or Beclin-1 immunoblotting, electron
microscopy or GFP-LC3 immunoﬂuorescence), these studies con-
sistently demonstrated an accumulation of autophagic vacuoles
in HCV-infected hepatocytes. This increase was independent of
HCV genotype since it was observed in vitro in cells harboring
the HCV strain H77 (genotype 1a), Con1 (genotype 1b) and
JFH1 (genotype 2a) [27,28,30] and also in patients infected with
HCV genotypes 1, 2, 3 and 4 [29]. However, this autophagy was
inefﬁcient. Indeed, although HCV JFH1 induced autophagosomes,
it was not able to enhance autophagic protein degradation [30].
Contrary to certain viruses such as vesicular stomatitis virus
and mutant herpes simplex virus 1, that can be captured and
eliminated by the autophagic pathway, HCV has evolved to avoid
and subvert autophagy using three strategies (Fig. 4) [26].
First, HCV seems to avoid its recognition by the autophagic
machinery. Indeed, both immuno-electron microscopy and
immunoﬂuorescence studies revealed no or rare co-localization
of HCV proteins with autophagic vacuoles [27,28,30,32].
Second, HCV prevents the maturation of the autophagosome
into an autolysosome, as supported by the following elements:
(a) the increase in the number of autophagic vacuole without
enhancement in autophagic protein degradation [30]; (b) the
absence of co-localization of lysosomes (stained with LysoTrac-
ker-red) with autophagic vacuoles (GFP-LC3) in HCV-infected
cells contrary to starved cells [30]; (c) the reduction in the num-
ber of autophagic vacuoles following HCV elimination using
interferon alpha for 14 days [31]; (d) the absence of increase in
the number of late autophagic vesicles in hepatocytes from
chronic hepatitis C patients as compared to controls, while a
strong augmentation in the number of autophagic vesicles is
observed [29]. This may be related to a lack of fusion between
autophagosome and lysosome.
Third, HCV utilizes functions or components of autophagy to
enhance its intracellular replication. Indeed, it has been recently
shown that autophagy proteins are required for translation and/
or delivery of incoming HCV RNA to the cell translation apparatus
[28]. However, autophagy proteins are not needed for the trans-
lation of progeny HCV once replication is established since down-
regulation of autophagy proteins 10 days after transduction had
no effect on HCV replication. Therefore, authors hypothesized
that, by remodelling endoplasmic reticulum membranes, the
autophagy proteins or autophagic vesicles might provide an ini-
tial membranous support for translation of incoming RNA, prior
to accumulation of viral proteins and the eventual establishment
of virus-induced cellular modiﬁcations. Alternatively, autophagy
proteins might contribute directly or indirectly to the cytoplas-
mic transport of the incoming RNA to cellular factors or sites that
are required for its translation [28]. Importantly, autophagy pro-
teins are required neither for HCV entry nor for HCV secretion
[28,32]. Altogether, these data explain the apparent contrast
between the results of some in vitro studies reporting the impli-
cation of autophagy proteins in HCV replication [30–32] and the
absence of correlation between the number of autophagic vacu-
oles or the LC3-II level and the HCV load in chronic hepatitis C
patients [29]: autophagy proteins are required only for initial
steps of HCV replication, but not once replication is established.
Notably, cytosolic RNA-sensing protein kinase PKR and eIF2-a
phosphorylation regulate virus- and starvation-induced autoph-
agy [33,34]. It is tempting to speculate that recognition of the
incoming HCV RNA by RNA-sensing molecules induces autophagyvol. 53 j 1123–1134
Table 1. Level and function of autophagy in liver diseases.
Liver disease ygahpotuA revilehtnilevel Function of autophagy
Liver ischemia reperfusion and liver surgery Cell survival 
Hepatitis C viral infection Autophagy machinery subverted by HCV 
Hepatitis B viral infection Autophagy machinery subverted by HBV 
Acute liver injury Cell survival or death depending on the stimulus 
Alpha1 antitrypsin deficiency Degradation of protein aggregates 
Alcoholic liver disease sellenagrodegamadfodnasetagergganietorpfonoitadargeD
Fatty liver disease Lipid degradation to fatty acid. Insulin signalling 
Hepatocellular carcinoma Anti-tumor 
JOURNAL OF HEPATOLOGYand hence, favours its initial translation. Alternatively, constitu-
tive basal autophagic vesicle formation might be required for this
initial HCV RNA translation.
In conclusion, these data show that autophagy proteins are
proviral factors for HCV.
HBV also induces autophagosomes in liver cells, as demon-
strated both in vitro in several liver derived cell lines and
in vivo in the liver of transgenic mouse lines harboring lowIsolation
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Fig. 4. HCV adaptations to evade and take advantage of autophagy. (1) HCV avoids its
autophagosome into an autolysosome. (3) HCV utilizes functions or components of au
surface receptors; (b) internalization; (c) fusion with endosomal membranes, allowing re
RNA; (e) HCV replication; (f) production of progeny viruses; (g) secretion. Atg, autophag
Journal of Hepatology 2010(Tg08) and high (Tg05) replication levels of the HBV DNA. Impor-
tantly, this induction was also observed in the liver of an HBV-
infected patient but not of a non-infected patient [35]. Contrary
to HCV, HBV can enhance the autophagic ﬂux, as late autophagic
vacuoles could be detected in mouse hepatocytes using electron
microscopy and given the existence of an extensive co-localiza-
tion of lysosome-associated membrane protein 1 (LAMP1) with
GFP–LC3 puncta (Fig. 5). However, without being able to provide-
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Reviewthe reason for it, no signiﬁcant increase in protein degradation
was observed in HBV DNA-transfected cells [35].
An HBV-encoding protein, HBx, plays a crucial role in this
HBV-induced autophagy [35,36]. Indeed, transfection of Huh7.5
cells with an HBV unable to express HBx did not enhance autoph-
agy. Moreover, expression of HBx alone was sufﬁcient to induce
autophagy; similar results were obtained in vivo in transgenic
mice [35]. This effect of HBx is due, at least partly, to its ability
to bind to class III PI3K, a regulatory molecule that controls
autophagy. Although conﬂicting, HBx may also upregulate the
transcription of beclin-1, a protein that forms a complex with
class III PI3K and thus sensitizes the cells to starvation-induced
autophagy [35,36]. Whether the role of HBx is conﬁned to short
nutrient starvation conditions (8 h) or also exists in normal con-
ditions remains controversial [35,36].
If, in the same way as HCV, HBV subverts autophagy, the strat-
egy applied is somewhat different (Fig. 5). Autophagy enhances
HBV replicationmostly at the step of viral DNA replication, slightly
at the step of RNA transcription, and not at other levels [35]. How
autophagymayenhanceHBVDNAreplication remains unresolved.
The question whether HBV could be engulfed in autophagic
vacuoles is not fully elucidated despite the observation that1128 Journal of Hepatology 2010HBV core/e antigens and surface antigens partially co-localized
with autophagic vacuoles [35]. Immuno-electron microscopy
studies would be required to address this issue. However, as
HBV seems to beneﬁt from autophagy proteins and as the auto-
phagic protein degradation rate is not increased, this hypothesis
seems unlikely and autophagic vacuoles may rather serve as the
sites for viral DNA replication and morphogenesis.Autophagy and acute liver injury
Data regarding autophagy in acute liver injury are scarce. Two
classic models of acute liver injury have been used: the concanav-
alin A and the lipopolysaccharide/D-galactosamine induced acute
hepatitis [37–40]. In both models, autophagy was enhanced in
mice liver. However, results are discordant for what regards the
suggested role of autophagy. In concanavalin A-induced acute
liver injury, concanavalin A induced autophagic cell death in
hepatocytes and likely also in liver endothelial cells [37–39].
On the contrary, in lipopolysaccharide/D-galactosamine-induced
acute liver injury, autophagy may be hepatoprotective. Indeed,
lipopolysaccharide/D-galactosamine increased autophagy in thevol. 53 j 1123–1134
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livers of both wild-type and transgenic mice deﬁcient of preg-
nane X receptor (PXR). Autophagy level was sustained in the for-
mer group but decreased rapidly in the latter. In parallel, the
transgenic mice displayed more severe liver injury than wild-
type mice [40] (Table 1).
However, the extrapolation of these data to human acute liver
injury is uncertain. Indeed, electron microscopy analysis per-
formed on liver biopsies from 5 patients with acute liver disease
(2 with autoimmune hepatitis, 1 drug induced acute liver injury,
1 acute fatty liver of pregnancy and 1 Mauriac syndrome) did not
show elements suggesting induction of autophagy [41].
Increased autophagy has only been reported in patients with
acute liver insufﬁciency in a context of anorexia nervosa, a rare
cause of liver failure. The role of autophagy in anorexia nervosa
seems to be dual. As illustrated in Figure 6, initially, when body
weight decreases, liver tests abnormalities are moderate, sug-
gesting that autophagy can cope with nutrient starvation. How-
ever, when undernutrition reaches a critical level (body mass
index at 13 or less), a ﬂare in alanine aminotransferase (ALT) level
occurs together with liver insufﬁciency. At that time, hepatocytes
contain numerous autophagic vacuoles and interestingly, some
liver cells present with the characteristic features of autophagic
cell death, also called type 2 programmed cell death. This type
of cell death could explain the contrast between the high serum
alanine aminotransferase level (on average 1900 IU/L) and the
absence of hepatocyte necrosis or liver cell apoptosis upon histo-
logical analysis. Indeed, while apoptosis cell plasma membrane
integrity is preserved, during autophagic cell death the perme-
ability increases, so that the aminotrasferase can be released in
the blood ﬂow [41]. Data obtained in perfused rat liver may
explain this dual action of autophagy, since authors show that
the degree of amino acid deprivation determines not only the
number of autophagic vacuoles but also the types of cytoplasmic
elements engulfed. Autophagic vacuoles initially contain glyco-
gen and smooth endoplasmic reticulum, and subsequently mito-
chondria, rough endoplasmic reticulum, and free ribosomes [12].
This second step may jeopardize cell survival, particularly in a
context of possible hypoxia, given the low cardiac output0 
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Journal of Hepatology 2010observed in these patients [42,43]. Altogether, these data suggest
that in acute liver injury, autophagy ﬁghts to keep cells alive
under stressful ‘‘life-threatening” conditions, the autophagic cell
death being the outcome of failed adaptation.Autophagy in alpha1-antitrypsin deﬁciency
The genetic disease alpha-1-antitrypsin (a1AT) deﬁciency is
caused by homozygosity for the a1AT mutant Z gene (ATZ) and
occurs 1 in 2000 births. The Z mutation confers an abnormal con-
formation on the nascent polypeptide, resulting in an accumula-
tion of the mutant protein within the endoplasmic reticulum of
hepatocytes rather than the appropriate, highly efﬁcient, secre-
tion of the wild-type protein.
When ATZ accumulates in the ER, it can be degraded by two
major mechanisms, the proteasomal and autophagic pathways.
The proteasome is probably specialized for the soluble forms of
ATZ that accumulates in the ER, presumably bound to multiple
chaperones [44]. Several lines of evidence show that the autopha-
gic pathway is specialized for the polymerized/aggregated forms
of ATZ (Table 1): (a) an increased accumulation of autophago-
somes is observed in ﬁbroblast cell lines engineered for the expres-
sion of mutant ATZ, in the liver cells of the PiZ mouse model of
a1AT deﬁciency and in the liver cells of patients with a1AT deﬁ-
ciency [45]; (b) these autophagic vacuoles contain ATZ as demon-
strated using both immuno-electron microscopy and
immunoﬂuorescence [45,46], but also frequently contain mito-
chondria, evenwhen comparedwith liver frompatientswith other
hepatic disorders [47]; (c) in cell lines deleted for the Atg5 gene,
that is necessary for autophagy, the degradation of ATZ is retarded
and the characteristic cellular inclusions of ATZ accumulate [46].
This induction of autophagy is speciﬁc for the aggregation-
prone properties of ATZ because it was not seen in a Saar mouse,
a mouse with hepatocyte-speciﬁc inducible expression of the AT
Saar variant that accumulates in the ER but does not polymerize/
aggregate [46].
The mechanisms by which autophagy is activated in the liver
in a1AT deﬁciency are largely unknown. The marked upregula-
tion of regulator of G signaling 16 (RGS16) observed both in the
liver of mice that have hepatocyte-speciﬁc inducible expression
of ATZ and in the liver of patients with a1AT deﬁciency may be
implicated [48]. Indeed, RGS16 binds to and inhibits the hetero-
trimeric G protein Gai3, a protein that inhibits hepatic insulin-
induced autophagic activity [49]. Therefore, RGS16 might de-
repress autophagy.
The pathogenesis of liver injury in a1AT deﬁciency is still
incompletely understood. Nevertheless, it has been shown that
markers of apoptosis are more pronounced in hepatocytes with
greater levels of insoluble ATZ. Furthermore, stimulation of the
extrinsic apoptotic pathway with antibody to Fas, resulted in
increased apoptosis almost exclusively of the globule-containing
cells [50]. Autophagy activation and/or mitochondrial dysfunc-
tion present in a1AT hepatocytes must therefore be responsible
for this increased apoptotic hepatocellular death.
Interestingly, recent studies have shown that carbamazepin, a
well-known food and drug administration-approved drug that
enhances autophagy, decreases the hepatic load of ATZ and hepa-
tic ﬁbrosis in a mouse model of AT deﬁciency-associated liver dis-
ease. These results provide a basis for testing carbamazepin in
a1AT deﬁciency patients [51,52].vol. 53 j 1123–1134 1129
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More details regarding the implication of autophagy in alpha-
1-antitrypsin deﬁciency are provided in a recent review [44].Autophagy in alcoholic liver disease
Excessive alcohol consumption is the third leading preventable
cause of death in the United States [53]. Chronic alcohol use
may cause several types of liver injury: fatty liver (also called ste-
atosis), hepatic ﬁbrosis, cirrhosis, and alcoholic hepatitis.
Several direct and indirect arguments suggest that alcohol
consumption suppresses liver cell autophagy (Table 1): (a) rats
chronically fed with ethanol have a reduced number of autopha-
gic vacuoles in liver cells, as determined morphometrically [54];
(b) chronic ethanol consumption slows down the catabolism of
long-lived proteins in the rat liver [54,55]; (c) alcohol abuse is
associated with protein accumulation in the liver, as demon-
strated in ethanol fed rats [56]; (d) hepatocytes from patients
with alcoholic steatohepatitis contain protein aggregates called
Mallory-Denk bodies. The major constituents of these cytoplas-
mic inclusions are cytokeratins 8 and 18, in association with
other proteins including ubiquitin and p62 [57,58]. These Mal-
lory-Denk bodies may witness a decrease in autophagy level.
Indeed, autophagy participates in the elimination of components
of Mallory-Denk bodies, since cytokeratin 8/18 are detected in
autophagic vacuoles using immuno-electron microscopy, and
since stimulating the autophagic process using rapamycin
decreases the number of these protein aggregates [57,59]; (e) loss
of autophagy in transgenic mice induces the formation of proteinmTOR 
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Fig. 7. Ethanol may decrease autophagy level by reducing AMPk activity in the liver (a)
autophagic process results in the accumulation of protein aggregates called Mallory-
Depolarization of the inner membrane of mitochondria may occur leading to mitoch
monophosphate-activated protein kinase; CK, cytokeratin; MDB, Mallory-Denk body.
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(f) ethanol also suppresses autophagy in cortical neuroepithelial
progenitors, suggesting that this effect is not restricted to liver
cells [61].
The mechanisms responsible for the decrease in autophagy
are not clear, but two explanations can be advanced [62]
(Fig. 7). First, ethanol consumption signiﬁcantly reduces adeno-
sine monophosphate-activated protein kinase (AMPk) activity
in the liver [66]. As shown in Figure 7, AMPk suppression reduces
autophagy via the mTOR pathway. Second, ethanol is known to
alter vesicle transport in hepatocytes. Autophagy requires the
action of cytoskeletal elements, including microtubules and
microﬁlaments. Both are necessary for autophagosome formation
and fusion with other vesicular bodies, as demonstrated by block-
ing these processes with speciﬁc inhibitors, including nocadazole
and vinblastine (microtubules), and cytochalasins (microﬁla-
ments) [63,64]. Disruption, by ethanol treatment, of the vesicular
movement within the hepatocyte, occurs by mechanisms that are
independent of the molecular motors dynein and kinesin,
although there is evidence for alterations in the protein dynamin
[65].
This decline in the autophagic pathway must contribute to the
pathological consequences of alcohol ingestion. First, as men-
tioned above, the decrease in protein catabolism likely contrib-
utes to the formation of Mallory-Denk bodies. These inclusions
contain the protein p62. Recent studies have demonstrated that
accumulation of p62 results in hyperactivation of the transcrip-
tion factor (nuclear factor erythroid 2-related factor 2 (Nrf2) that
causes liver changes such as hepatomegaly, liver cell swelling,a 
b 
Cytoplasm 
Nucleus 
b 
Ethanol
l
-
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and by disrupting vesicular movement within hepatocyte (b). This decrease in the
Denk bodies (c) and of mitochondria damaged following ethanol ingestion (d).
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and aminotransferase elevation [67]. Second, ethanol causes
mitochondrial damage leading, in certain cases, to depolarization
of the inner membrane of mitochondria, called mitochondrial
permeability transition. It is crucial that such damaged mito-
chondria be removed from the cell by engulfment in autophagic
vacuoles. The absence of mitochondrial autophagy leads to
uncoupling of oxidative phosphorylation and cell death [16,62].Nucleus 
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P
P
P
P
P
P
P
PIP3
PIP2
Class I 
PI3K 
IRS
P
ER 
stress
ld
Fatty
acids
ld
ld
calpain
Obesity
Atg 
PAkt/
PKB
FoxO
mTOR 
ld
-
--
-
-
Lysosome 
Fig. 8. Fatty liver disease and metabolic syndrome. Under physiological
conditions (black arrows), autophagy functions in the basal turnover of lipids
by engulﬁng and degrading lipid droplets. Autophagy is inhibited by the insulin
amino acid-mTOR signaling pathway via both short-term and long-term regu-
lation mechanisms. Short-term inhibition can be produced by the mTOR complex.
Long-term regulation occurs via the transcription factors FoxO [72], which control
the transcription of autophagy genes and become inhibited by insulin-induced
activation of protein kinase B. In obesity (red arrows), autophagy level is
decreased in hepatocytes. Several mechanisms may account for this decline. First,
obesity-induced increase in the calcium-dependent protease calpain 2 leads to
down-regulation of Atg7 and then defective autophagy. Acute inhibition of
calpain is able to restore Atg7 expression [71]. Second, in obesity, the autophagy
inhibitor mTOR is overactivated in the liver, presumably as the result of increased
amino acid concentrations following overnutrition [73,87]. Third, although
controversial, hyperinsulinemia may also contribute to downregulating autoph-
agy in obese mice. Indeed, inhibiting Akt which is a key molecule in the insulin
pathway, increases autophagy in the liver of obese mice [72]. However,
destruction of insulin production in b-cells by streptozotocin does not increase
autophagy in the liver of obese mice [71], contrary to lean mice [72]. The reasons
for these discrepancies are unclear. In obesity, defect in autophagy and its
associated decrease in lysosomal degradation rate contribute to further increas-
ing the ER stress induced by nutrient overload in an inﬂammatory milieu [71,75].
Together, autophagy decline and ER stress lead to insulin resistance [71].
Abbreviations: Atg, autophagy genes; ld, lipid droplet; ER, endoplasmic reticulum;
mTOR, mammalian target of rapamycin; PKB, protein kinase B.Autophagy and non alcoholic fatty liver disease
The implication of autophagy in hepatocyte lipid metabolism has
been recently demonstrated [68]. Besides cytosolic lipases,
autophagy regulates intracellular lipid stores through a process
called macrolipophagy. Portions of lipid droplets, or even whole
droplets, become trapped inside the double-membrane-bound
autolipophagosome vesicles and are transported to lysosomes,
where they are degraded to fatty acids (Fig. 8). The presence of
this alternative lipid degradative pathway in hepatocytes
explains their ability to rapidly mobilize large amounts of lipids
despite their low levels of cytosolic lipases in comparison with
adipocytes [69,70]. In physiological state, both lipolysis and mac-
rolipophagy are inhibited by the hormone insulin [5,8,68,69].
The efﬁciency of macrolipophagy varies with the nutritional
status. In response to a short-term increase in lipid availability,
in vitro studies have demonstrated that the autophagy level
increases, leading to a greater breakdown of stored lipids to sup-
ply fatty acids for b-oxidation or other uses [68]. In the same way,
hepatocyte-speciﬁc atg7-knockout mice had markedly increased
hepatic lipid [68].
In contrast, in both genetic (ob/ob mice) and dietary (high fat
diet) mouse models of chronic obesity and insulin resistance, a
sustained increase in lipid availability results in markedly
decreased hepatic autophagy indicators [68,70–73]. Proposed
mechanisms are summarized in Figure 8.
This decreased autophagy level impacts on other cellular func-
tions andparticularly on ER stress. Indeed, in the liver tissue of lean
mice, deﬁciency of autophagy, induced by suppression of Atg7,
results in ER stress [71]. This could be explained by the known role
of autophagy in the degradation of unfolded proteins and in the
removal of superﬂuous ER membranes: defect in autophagy may
lead to the accumulation of unfolded proteins and thus to ER stress
[74]. In obesity, ER function is compromised due to nutrient and
energy surplus in an inﬂammatory milieu [75]. Concomitantly,
autophagy level is decreased, suggesting that failure to achieve
autophagy may further impair ER function in the face of continu-
ous energy and nutrient stress, engage organelle dysfunction and
contribute to insulin resistance, a known consequence of ER stress
[71,76]. Interestingly, restoration of Atg7 expression results in sig-
niﬁcant reduction in obesity-induced ER stress in the liver of ob/ob
mice, rescues the defects in insulin receptor signaling, reduces
serum insulin level, improves glucose tolerance and whole body
insulin sensitivity through the suppression of hepatic glucose pro-
duction and enhancement of insulin-stimulated glucose disposal
in the periphery, and decreases hepatic fatty acid inﬁltration and
liver triglyceride content [68,71]. However, the interest of increas-
ing autophagy, e.g., by pharmacological means, remains uncertain
given the opposite role of autophagy in adipocytes: the inhibition,
rather than the stimulation, of autophagy in adipocytes gives them
a brown-fat-cell-like appearance that favours fatty acid oxidation
and increases insulin [68,73].Journal of Hepatology 2010Autophagy and hepatocellular carcinoma
Early, cancer has been genetically linked to autophagy malfunc-
tion. Indeed, the ATG gene beclin-1 is mono-allelically deleted
in 40–75% of cases of human breast, ovarian, and prostate cancer
[5,77,78]. Moreover, the regulation of autophagy overlaps closely
with signaling pathways that regulate tumorigenesis.vol. 53 j 1123–1134 1131
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Studies assessing autophagy in hepatocellular carcinoma
(HCC) have clearly demonstrated in vitro, in mice and in patients
that, in this context, autophagy is a tumor suppressor mechanism
(Table 1).
First, mice with heterozygous disruption of beclin-1 have a
high frequency of spontaneous hepatocellular carcinoma. More-
over, crossing beclin-1 +/ mice, with mice, that transgenically
express the HBV large-envelope polypeptide under the transcrip-
tional control of the mouse albumin promoter, resulted in the
acceleration of the development of hepatitis B virus-induced
small-cell dysplasia – an important histopathologic predictor of
malignant transformation [79].
Second, expression of several autophagic genes (ATG5, ATG7
and BECLIN-1) and their corresponding autophagic activity is
decreased in HCC cell lines compared to that in a normal hepatic
cell line. Similarly, Beclin-1 mRNA and protein levels are lower in
HCC tissue samples than in adjacent non-tumor tissues from the
same patients [80].
Third, the most aggressive malignant HCC cell lines and HCC
tissues with recurrent disease display much lower autophagic
levels than less aggressive cell lines or tissues, especially when
the anti-apoptotic B-cell leukemia/lymphoma (Bcl)-xL protein is
over-expressed [80]. Interestingly, in a tissue microarray study
consisting of 300 HCC patients who underwent curative resec-
tion, the expression of Beclin-1 was signiﬁcantly correlated with
disease-free survival and overall survival only in the Bcl-xL+
patients. Multivariate analyses revealed that Beclin-1 expression
was an independent predictor for disease-free survival and over-
all survival in Bcl-xL+ patients. In addition, there was a signiﬁcant
correlation between Beclin-1 expression and tumor differentia-
tion in Bcl-xL+ but not in Bcl-xL HCC patients. These data sug-
gest that autophagy defect synergizes with altered apoptotic
activity and facilitates tumor progression and poor prognosis of
HCC [80].
The mechanisms responsible for this low autophagy protein
level are not elucidated. However, a recent study has demon-
strated that HAb18G/CD147, a transmembrane glycoprotein
highly expressed in HCC, contributes to this decreased autopha-
gic level in HCC through the class I phosphatidylinositol 3-
kinase–Akt pathway upregulation [81]. Other oncoproteins such
as the Bcl-2 family proteins may also be implicated in HCC, like
in other cancers [77]. Stimulation of hypoxia-inducible factors
(HIFs) due to hypoxic stress within HCC may also contribute to
autophagy modulation [82].
Fourth, therapeutic approaches aiming at increasing autoph-
agy level have been successfully tested in vitro and/or in mice
using molecules such as Concanavalin A, a lectin with mannose
speciﬁcity [38], or cyclo-oxygenase-2 inhibitors [83,84]. Impor-
tantly, a large recent study has assessed the survival after liver
transplantation according to the immunosuppression protocol
administrated. All patients included, 2491 adult recipients of iso-
lated liver transplantation for HCC and 12,167 for non-HCC,
remained on stable maintenance immunosuppression protocols
for at least 6 months post-transplant. Therapy using rapamycin,
a well-known activator of autophagy, was associated with
improved survivals after transplantation for HCC. Interestingly,
in non-HCC patients, rapamycin showed a trend toward lower
rates of survival in non-HCC recipients, conﬁrming the speciﬁcity
of its beneﬁcial impact for cancer patients [85].
Given the primary prosurvival role of autophagy, this anti-
tumor activity may be surprising. If the mechanisms for this1132 Journal of Hepatology 2010tumor suppressor role of autophagy are not yet clear, the follow-
ing functions of autophagy have been proposed: (a) limiting chro-
mosomal instability therefore preventing the accumulation of
oncogenic mutations; (b) restricting oxidative stress, which is
also an oncogenic stimulus; and (c) reducing intratumoral necro-
sis and local inﬂammation [77,78].Conclusion
Autophagy has a Janus-face in that being primarily a survival
mechanism it can also, under certain conditions, lead to autopha-
gic cell death. However, in most liver diseases, it seems clear that
one of its major functions is to ﬁght to keep cells alive under
stressful ‘‘life-threatening” conditions. Conversely, during hepati-
tis viral infection, autophagy is subverted to the beneﬁt of the
virus. Hence, taking into account the crucial role of autophagy
in liver diseases and the existence of therapies targeting this pro-
cess, such as rapamycin, makes therapeutic strategies targeting
autophagy possible in a near future [8,17,88]
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